The flagship transcatheter heart valve of Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has been successfully implanted during a valve-in-valve procedure as.
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) says new data from its first-in-human DurAVR™ transcatheter heart valve trial represent the best results to.
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has formed a partnership with v2vmedtech, Inc. to create a novel heart valve repair device for minimally.